Methyl 5-(1-Methyl-2-pyrrolyl)isoxazole-3-carboxylate
- $65 - $1275
- Product name: Methyl 5-(1-Methyl-2-pyrrolyl)isoxazole-3-carboxylate
- CAS: 1375064-53-1
- MF: C10H10N2O3
- MW: 206.2
- EINECS:
- MDL Number:MFCD22192341
- Synonyms:Methyl 5-(1-Methyl-2-pyrrolyl)isoxazole-3-carboxylate;3-Isoxazolecarboxylic acid, 5-(1-methyl-1H-pyrrol-2-yl)-, methyl ester;Methyl 5-(1-methyl-1H-pyrrol-2-yl)isoxazole-3-carboxylate
4 prices
Selected condition:
Brand
- AK Scientific
- Chemenu
- Crysdot
- TRC
Package
- 50mg
- 5g
- ManufacturerAK Scientific
- Product number7083AJ
- Product descriptionMethyl5-(1-methyl-2-pyrrolyl)isoxazole-3-carboxylate
- Packaging5g
- Price$1275
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM320425
- Product descriptionmethyl5-(1-methyl-1H-pyrrol-2-yl)isoxazole-3-carboxylate 95%
- Packaging5g
- Price$799
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11269671
- Product descriptionMETHYL5-(1-METHYL-2-PYRROLYL)ISOXAZOLE-3-CARBOXYLATE 95+%
- Packaging5g
- Price$855
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM221910
- Product descriptionMethyl5-(1-Methyl-2-pyrrolyl)Isoxazole-3-carboxylate
- Packaging50mg
- Price$65
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 7083AJ | Methyl5-(1-methyl-2-pyrrolyl)isoxazole-3-carboxylate | 5g | $1275 | 2021-12-16 | Buy |
Chemenu | CM320425 | methyl5-(1-methyl-1H-pyrrol-2-yl)isoxazole-3-carboxylate 95% | 5g | $799 | 2021-12-16 | Buy |
Crysdot | CD11269671 | METHYL5-(1-METHYL-2-PYRROLYL)ISOXAZOLE-3-CARBOXYLATE 95+% | 5g | $855 | 2021-12-16 | Buy |
TRC | M221910 | Methyl5-(1-Methyl-2-pyrrolyl)Isoxazole-3-carboxylate | 50mg | $65 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||
Precautionary statements: |
|